BCG Vaccine Market

The numerous benefits of multi-flue chimney caps and other major driving factors is expected to favour the rise in the global BCG vaccine market


Reports and Insights has published a new report titled, “BCG Vaccine Market: Opportunity Analysis and Future Assessment 2020-2028

Global BCG Vaccine Market, By Drug Type (Immune BCG, Therapy BCG), By Usage (Tuberculosis, Bladder Cancer), By End User (Pediatrics, Adults) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, & Africa) is expected to grow at a significant CAGR for the period between 2020 and 2028.

The global BCG vaccine market in 2020 is estimated for more than US$ xx Bn and expected to reach a value of US$ xx Bn by 2028 with a significant CAGR of xx%.

Bacille Calmette-Guérin (BCG) is generally a vaccine that offers a safety shield against tuberculosis (TB) infection. It is believed to be about 70-80% effective in counter to the most acute forms of TB, for instance TB meningitis. Having said that, it is not so effective in prohibiting the kind of TB that impacts the lungs. The BCG vaccine comprises live bacteria that have been attenuated or simply weakened, in such a way that they galvanize the immune system but do not induce infection in healthy people.

The growing prevalence of tuberculosis (TB) among the population all across the world is one of the major factors that is primarily propelling the demand of BCG vaccine across the global markets. In addition to that, the increasing immunization programmes by the governments for the protection of newborns from various acute diseases is further projected to encourage the demand of BCG vaccines across the globe. Attributing to which, the global BCG vaccine market is expected to witness considerable growth in the following years.

In addition to that, the rapid advancements in the medical and healthcare industry along with several technological advancements is further estimated to offer major breakthroughs to the BCG vaccine market growth over the years.

However, lack of BCG vaccines in some of the merging regions worldwide is likely to slow down the market growth in the near future. Furthermore, the adverse effects associated with BCG vaccines is also estimated to hamper the future growth of the market.

Reports and Insights Study identifies some of the key participating players in the BCG vaccine market globally are Merck & Co., Inc., Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group (a subsidiary of China National Pharmaceutical Group Corporation), Serum Institute of India Pvt. Ltd. InterVax Ltd. GreenSignal Bio Pharma Limited (GSBPL), Statens Serum Institut, among others.

About Reports and Insights

Reports and Insights is one of the leading market research companies which offers syndicate and consulting research around the globe. At Reports and Insights we adhere to the client needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with a strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.

Contact Us

Reports and Insights

Tel: +1-(718)-312-8686

For Sales Query: [email protected]

For New Topics & Other Info: [email protected]

1820 Avenue M, Brooklyn, NY 11230, United States
315,Shopping Center,Kota-324007,Rajasthan
Suite -104, D-20, Sector-63, Noida. Uttar Pradesh - 201014, India

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy